Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America SENTRY Antimicrobial Surveillance Program, 1997-2000

被引:77
作者
Diekema, DJ
Pfaller, MA
Jones, RN
机构
[1] Univ Iowa, Coll Med, Med Microbiol Div, Dept Pathol, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
[4] Jones Grp, JMI Labs, Iowa City, IA USA
关键词
antimicrobial resistance; surveillance; bloodstream infection;
D O I
10.1016/S0924-8579(02)00204-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report age-related trends in pathogen frequency and antimicrobial susceptibility from 25,745 bloodstream infections (BSI) due to bacterial pathogens reported from medical centres participating in the North American SENTRY Antimicrobial Surveillance Program between January 1997 and September 2000. Staphylococcus aureus, Escherichia coli and coagulase-negative staphylococci (CoNS) were the most common pathogens, together accounting for 55% of all BSI pathogens during this time period. Among nosocomial BSI, CoNS were the most frequently isolated pathogens in infants less than I year of age, but S. aureus increased in frequency with increasing age. Among community-onset BSI pathogens, Streptococcus pneumoniae was the most frequently reported pathogen causing BSI in patients aged 1-5, S. aureus among those aged 6-64, and E. coli predominated at the extremes of age (less than I year and ! 65 years of age). Among key organism: antimicrobial agent combinations evaluated, oxacillin resistance in S. aureus increased with increasing age; conversely, oxacillin resistance among CoNS was highest among children 5 years of age or younger. Penicillin resistance among S. pneumoniae BSI was highest in children younger than 5 years, while vancomycin resistance among Enterococcus spp. predominated among nosocomial BSI in patients over 50 years of age. Important age-related differences exist in species distribution and antimicrobial susceptibility of pathogens causing BSI. This information should be helpful for clinicians as they consider empirical antimicrobial therapy for patients with suspected BSI across the age continuum. (C) 2002 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:412 / 418
页数:7
相关论文
共 36 条
  • [21] GRAM-NEGATIVE BACTEREMIA .2. CLINICAL, LABORATORY, AND THERAPEUTIC OBSERVATIONS
    MCCABE, WR
    JACKSON, GG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1962, 110 (06) : 856 - &
  • [22] MCDONALD LC, 2001, 11 ANN SCI M SOC HEA
  • [23] Murray P.R., 1999, MANUAL CLIN MICROBIO, V7th
  • [24] *NAT COMM CLIN LAB, 2000, M100S10 NAT COMM CLI
  • [25] *NAT COMM CLIN LAB, 2000, M7A4 NAT COMM CLIN L
  • [26] Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
    Pfaller, MA
    Jones, RN
    Doern, GV
    Kugler, GVDK
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1762 - 1770
  • [27] NOSOCOMIAL BLOOD-STREAM INFECTION IN CRITICALLY ILL PATIENTS - EXCESS LENGTH OF STAY, EXTRA COSTS, AND ATTRIBUTABLE MORTALITY
    PITTET, D
    TARARA, D
    WENZEL, RP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (20): : 1598 - 1601
  • [28] Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission
    Rezende, NA
    Blumberg, HM
    Metzger, BS
    Larsen, NM
    Ray, SM
    McGowan, JE
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (03) : 117 - 123
  • [29] Nosocomial infections in pediatric intensive care units in the United States
    Richards, MJ
    Edwards, JR
    Culver, DH
    Gaynes, RP
    [J]. PEDIATRICS, 1999, 103 (04) : art. no. - e39
  • [30] Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with The Surveillance Network Database - USA
    Sahm, DF
    Marsilio, MK
    Piazza, G
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 259 - 263